首页|Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma

Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma

扫码查看

Dinesh Babu Somasundaram、Andrew Maher、Sheeja Aravindan、Zhongxin Yu、Brian M.Besch、Natarajan Aravindan

展开 >

Department of Radiation Oncology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA

Stephenson Cancer Center,Oklahoma City,OK,USA

Department of Pathology,University of Oklahoma Health Sciences Center,Oklahoma City,OK,USA

Radiation Biology Laboratory,University of Oklahoma Health Sciences Center,BSEB 302F,941 Stanton L.Young Boulevard,Oklahoma City,OK 73104,USA

展开 >

Oklahoma Center for the Advancement of Science and TechnologyDepartment of Defense,DoD Peer Reviewed Cancer Research Program美国国立卫生研究院项目National Cancer Institute Cancer Center Support GrantOklahoma Tobacco Settlement Endowment Trust

OCAST-HR19-045CA-210339P20GM103639P30CA225520R23-03

2024

世界儿科杂志(英文版)

世界儿科杂志(英文版)

CSTPCD
ISSN:
年,卷(期):2024.20(3)
  • 20